Delta Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,405
Closed -$411K 301
2026
Q1
$411K Sell
1,405
-27,287
-95% -$8.97M 0.07% 166
2025
Q4
$10.1M Buy
28,692
+5,080
+22% +$1.72M 1.75% 13
2025
Q3
$7.63M Buy
+23,612
New +$7.34M 1.37% 21
2025
Q2
Sell
-8,777
Closed -$3.82M 245
2025
Q1
$3.82M Sell
8,777
-210
-2% -$84.3K 0.77% 28
2024
Q4
$3.32M Buy
+8,987
New +$3.76M 0.65% 28

Other funds holding ELV

Delta Investment Management's ELV Position: Q2 2026 in Review

Delta Investment Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 1,405 shares — an estimated $411K sold.

Delta Investment Management first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $10.1M in Q4 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Delta Investment Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Delta Investment Management sold 1,405 Elevance Health shares in Q2 2026, an estimated $411K.
  • Delta Investment Management first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
  • Delta Investment Management's Elevance Health position peaked at $10.1M in Q4 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Delta Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.